LATEST ARTICLES
- Talking Point with PCI Pharma Services
- The Importance of Conducting Diverse US Trials for US Cancer Patients
- An Open Letter of Appreciation to Clincial Trial Participants, Patient Advisors, Caregivers and HealthCare Professionals
- Early Adoption of an Integrated Product Development Strategy will Reap Dividends
- Bridging the Gaps in the Analytical Procedure with Bayesian Statistics
Current features
Continue Reading →
Talking Point with PCI Pharma Services
PCI Pharma Services is a trusted partner for globally integrated CDMO services. Can you tell our readers the brief history of your company, how the …
Current features
Continue Reading →
The Importance of Conducting Diverse US Trials for US Cancer Patients
Since the early 1990s, overall cancer death rates have declined for most cancers in the US. According to the Annual Report to the Nation on …
Current features
Continue Reading →
An Open Letter of Appreciation to Clincial Trial Participants, Patient Advisors, Caregivers and HealthCare Professionals
Thank you! Those of us who have dedicated our careers to medical and health sciences share a mission to improve the lives of people everywhere …
Current features
Continue Reading →
Early Adoption of an Integrated Product Development Strategy will Reap Dividends
With both the cost and time to bring a drug to market ballooning, the importance of an integrated product development (IPD) strategy is gaining traction. …
Current features
Continue Reading →
Bridging the Gaps in the Analytical Procedure with Bayesian Statistics
The ICH-Q2 has stated that the objective of validation of an analytical procedure is to demonstrate that it is suitable for its intended purpose, yet …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
Journal For Clinical Studies © 2022, All Rights Reserved – Powered by Teksyte
